How many shares of MRNS does UBS Group AG own?

UBS Group AG previously held 0 shares of MRNS (MARINUS PHARMACEUTICALS INC) before exiting the position in 2025-Q1.

What is UBS Group AG's MRNS position worth?

UBS Group AG's MRNS position was last reported at $0 in 2025-Q1 before the exit.

In 2025-Q1, UBS Group AG exited their MRNS position entirely (-100.0% change in shares).

Based on available 13F filings, UBS Group AG first reported a position in MRNS in 2019-Q1. They have held the position across 25 quarters.

Position history for UBS Group AG's holdings in MARINUS PHARMACEUTICALS INC

Final Value

Final Shares

Total Value Change

-$305,000

Total Shares Change

-72,857

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q1 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q4	Increased	258,944	+114x	$138,535	0.0%	—	24
2024-Q3	Decreased	2,258	-88.1%	$3,974	0.0%	—	0
2024-Q2	Decreased	19,045	-84.6%	$22,283	0.0%	—	0
2024-Q1	Increased	123,852	+49.1%	$1.1M	0.0%	—	35
2023-Q4	Increased	83,070	+48.0%	$902,971	0.0%	—	34
2023-Q3	Increased	56,144	+56.1%	$451,959	0.0%	—	34
2023-Q2	Decreased	35,973	-57.5%	$390,667	0.0%	—	0
2023-Q1	Increased	84,752	+11.8%	$584,789	0.0%	—	27
2022-Q4	Decreased	75,836	-21.3%	$301,827	0.0%	—	0
2022-Q3	Increased	96,375	+0.2%	$641,000	0.0%	—	24
2022-Q2	Increased	96,197	+183.5%	$465,000	0.0%	—	39
2022-Q1	Decreased	33,937	-32.4%	$317,000	0.0%	—	0
2021-Q4	Increased	50,214	+56.3%	$597,000	0.0%	—	35
2021-Q3	Increased	32,118	+4.8%	$366,000	0.0%	—	25
2021-Q2	Increased	30,651	+45.9%	$550,000	0.0%	—	33
2021-Q1	Increased	21,009	+2.0%	$325,000	0.0%	—	24
2020-Q4	Increased	20,597	+45.6%	$252,000	0.0%	—	31
2020-Q3	Decreased	14,142	-75.1%	$182,000	0.0%	—	0
2020-Q2	Decreased	56,707	-17.2%	$144,000	0.0%	—	0
2020-Q1	Decreased	68,496	-22.2%	$139,000	0.0%	—	0
2019-Q4	Increased	88,089	+32.2%	$191,000	0.0%	—	29
2019-Q3	Decreased	66,626	-13.2%	$103,000	0.0%	—	0
2019-Q2	Increased	76,732	+5.3%	$318,000	0.0%	—	25
2019-Q1	New	72,857	-	$305,000	0.0%	—	32